Review of the safety and efficacy of imiglucerase treatment of Gaucher disease
Deborah Elstein, Ari ZimranGaucher Clinic, Shaare Zedek Medical Center, Jerusalem, IsraelAbstract: Most patients who suffer from symptomatic Gaucher disease will benefit from enzyme replacement therapy (ERT) with imiglucerase. The safety profile is excellent, only a small percentage of those exposed...
Saved in:
Main Authors: | , |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2009
|
Subjects: | |
Online Access: | https://doaj.org/article/93035db7d71c4af793571bee8f3201da |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|